Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
The REMAP-CAP, ACTIV-4a, and ATTACC InvestigatorsNew Eng J Med, 2021, online August
Comment
There have been 2 REMP-CAP / ACTIV-4a / ATTACC anticoagulation in hospitalised patients with COVID studies published this month in NEJM;
Therapeutic anticoagulation with heparin in critically ill patients with COVID-19
This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules,
exam preparation tools, teaching aids and much more, login here, or Become a Member to register
Become a member
Comment
There have been 2 REMP-CAP / ACTIV-4a / ATTACC anticoagulation in hospitalised patients with COVID studies published this month in NEJM;
This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register